Multiple polymorphic loci determine basal hepatic and splenic iron status in mice

Hepatology

Volumn 44, Issue 1, 2006, Pages 174-185

  Grant, Gemma R ^a   Robinson, Susan W ^a   Edwards, Richard E ^a   Clothier, Bruce ^a   Davies, Reginald ^a   Judah, David J ^a   Broman, Karl W ^b   Smith, Andrew G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; HEME; IRON; TRANSFERRIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11; CHROMOSOME 16; CHROMOSOME 19; CHROMOSOME 2; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME POSITIONING; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE MAPPING; GENETIC CROSS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; IRON TRANSPORT; LIVER; MALE; MOUSE; NONHUMAN; PHENOTYPE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE TRAIT LOCUS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALS; CHROMOSOMES, MAMMALIAN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOCHROMATOSIS; IRON; LIVER; MICE; MICE, INBRED C57BL; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI; RNA, MESSENGER; SPLEEN; TRANSFERRIN;

EID: 33745892389     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21233     Document Type: Article

References (50)

1. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004;117:285-297.
2. Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 2002;33:457-463.
3. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000;66:1246-1258.
4. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218.
5. McCune CA, Al-Jader LN, May A, Hayes SL, Jackson HA, Worwood M. Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 2002;111:538-543.
6. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996;16:65-82.
7. Wolff B, Volzke H, Ludemann J, Robinson D, Vogelgesang D, Staudt A, et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004;35:453-457.
8. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. Br Med J 1998;317:727.
9. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994;56:364-369.
10. Nakano M, Kawanishi Y, Kamohara S, Uchida Y, Shiota M, Inatomi Y, et al. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. Free Radic Biol Med 2003;35:826-832.
11. Rouault TA. Iron on the brain. Nat Genet 2001;28:299-300.
12. Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol 2004;2:946-953.
13. Spivak JL. Iron and the anemia of chronic disease. Oncology (Williston Park) 2002;16:25-33.
14. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 2000;105:1209-1216.
15. Sproule TJ, Jazwinska EC, Britton RS, Bacon BR, Fleming RE, Sly WS, et al. Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci U S A 2001;98:5170-5174.
16. Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 2001;98:2707-2711.
17. Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 2004;126:1400-1408.
18. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
19. Dupic F, Fruchon S, Bensaid M, Borot N, Radosavljevic M, Loreal O, et al. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology 2002;122:745-751.
20. Leboeuf RC, Tolson D, Heinecke JW. Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains. J Lab Clin Med 1995;126:128-136.
21. Morse AC, Beard JL, Jones BC. A genetic developmental model of iron deficiency: biological aspects. Proc Soc Exp Biol Med 1999;220:147-152.
22. Smith AG, Clothier B, Francis JE, Gibbs AH, De Matteis F, Hider RC. Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3- hydroxypyridin-4-one in C57BL/10ScSn mice. Blood 1997;89:1045-1051.
23. Clothier B, Robinson S, Akhtar RA, Francis JE, Peters TJ, Raja K, et al. Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress. Biochem Pharmacol 2000;59:115-122.
24. Gerhard GS, Kaufmann EJ, Wang X, Erikson KM, Abraham J, Grundy M, et al. Genetic differences in hepatic lipid peroxidation potential and iron levels in mice. Mech Ageing Dev 2002;123:167-176.
25. Dupic F, Fruchon S, Bensaid M, Loreal O, Brissot P, Borot N, et al. Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut 2002;51:648-653.
26. Ajioka RS, LeBoef RC, Kushner JP. Mapping genes that influence iron metabolism using mouse chromosome substitution strains. Blood 2003;102:756a.
27. Jones BC, Reed CL, Hitzemann R, Wiesinger JA, McCarthy KA, Buwen JP, et al. Quantitative genetic analysis of ventral midbrain and liver iron in BXD recombinant inbred mice. Nutr Neurosci 2003;6:369-377.
28. Turner OC, Keefe RG, Sugawara I, Yamada H, Orme IM. SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis. Infect Immun 2003;71:5266-5272.
29. Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, et al. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am J Pathol 2005;166:1041-1053.
30. Robinson SW, Clothier B, Akhtar RA, Yang AL, Latour I, Van Ijperen C, et al. Non-ahr gene susceptibility loci for porphyria and liver injury induced by the interaction of 'dioxin' with iron overload in mice. Mol Pharmacol 2002;61:674-681.
31. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003;19:889-890.
32. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994;138:963-971.
33. Smith AG, Davies R, Dalton TP, Miller ML, Judah D, Riley J, et al. Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse. EHP Toxicogenomics 2003;111:45-51.
34. Zhang SD, Gant TW. A statistical framework for the design of microarray experiments and effective detection of differential gene expression. Bioinformatics 2004;20:2821-2828.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408.
36. Gorman N, Walton HS, Bement WJ, Honsinger CP, Szakacs JG, Sinclair JF, et al. Role of small differences in CYP1A2 in the development of uroporphyria produced by iron and 5-aminolevulinate in C57BL/6 and SWR strains of mice. Biochem Pharmacol 1999;58:375-382.
37. Muckenthaler M, Roy CN, Custodio AO, Minana B, deGraaf J, Montross LK, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 2003;34:102-107.
38. Krijt J, Cmejla R, Sykora V, Vokurka M, Vyoral D, Necas E. Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice. J Hepatol 2004;40:891-896.
39. Coursclaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, Leroyer P, et al. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol Dis 2004;32:283-289.
40. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, Szajnert MF, Kahn A, et al. Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 2004;103:2816-2821.
41. Lambert LA, Perri H, Meehan TJ. Evolution of duplications in the transferrin family of proteins. Comp Biochem Physiol B Biochem Mol Biol 2005;140:11-25.
42. Elder GH. Porphyria cutanea tarda and related disorders. In: Kadish KM, Smith KM, Guilard R, eds. The Porphyrin Handbook; vol 14, Medical Aspects of Porphyrins. Amsterdam, The Netherlands: Elsevier, 2003:67-92.
43. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, Leroyer P, Gilot D, et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002;277:41163-41170.
44. Cohen BL. A revised nomenclature for the mouse transferrin locus. Genet Res 1961;2:306-308.
45. Kasvosve I, Delanghe JR, Gomo ZA, Gangaidzo IT, Khumalo H, Wuyts B, et al. Transferrin polymorphism influences iron status in blacks. Clin Chem 2000;46:1535-1539.
46. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001;291:1755-1759.
47. de Sousa M, Reimao R, Lacerda R, Hugo P, Kaufmann SH, Porto G. Iron over-load in beta 2-microglobulin-deficient mice. Immunol Lett 1994;39:105-111.
48. Rothenberg BE, Voland JR. Beta2 knockout mice develop parenchymal iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci U S A 1996;93:1529-1534.
49. Tada N, Kimura S, Hatzfeld A, Hammerling U. Ly-m11: the H-3 region of mouse chromosome 2 controls a new surface alloantigen. Immunogenetics 1980;11:441-449.
50. Waheed A, Grubb JH, Zhou XY, Tomatsu S, Fleming RE, Costaldi ME, Britton RS, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 2002;99:3117-3122.